William B. Walkup & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
20,499
-663
-3% -$59.2K 1.02% 27
2026
Q1
$1.43M Buy
21,162
+837
+4% +$64.5K 0.86% 30
2025
Q4
$1.61M Sell
20,325
-821
-4% -$64.7K 0.88% 31
2025
Q3
$1.59M Hold
21,146
0.85% 30
2025
Q2
$1.46M Sell
21,146
-16
-0.1% -$1.05K 0.86% 33
2025
Q1
$1.43M Buy
21,162
+458
+2% +$27.4K 0.87% 29
2024
Q4
$929K Sell
20,704
-605
-3% -$33.9K 0.59% 43
2024
Q3
$1.34M Sell
21,309
-176
-0.8% -$10.3K 0.83% 30
2024
Q2
$1.27M Buy
+21,485
New +$1.34M 0.83% 31

Other funds holding CVS

William B. Walkup & Associates's CVS Position: Q2 2026 in Review

William B. Walkup & Associates reduced its CVS Health (CVS) stake by 3.1% in Q2 2026, selling an estimated $59.2K and leaving 20,499 shares worth $2.12M. The position accounts for 1.02% of the portfolio, ranked #27.

William B. Walkup & Associates first reported a position in CVS in Q2 2024 and has held it in 9 quarters since. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • William B. Walkup & Associates held 20,499 shares of CVS Health worth $2.12M as of Q2 2026.
  • William B. Walkup & Associates sold 663 CVS Health shares in Q2 2026, an estimated $59.2K.
  • CVS Health made up 1.02% of William B. Walkup & Associates's portfolio in Q2 2026, its #27 holding.
  • William B. Walkup & Associates first reported a position in CVS Health in Q2 2024 and has held it in 9 quarters since.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.